Gene · 5300
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stress granules at the crossroads of retroviral replication and antiviral immunity: mechanisms and therapeutic opportunities. | Mol Biol Rep | 2026 | 41931190 | PubTator, text mining | PubMed |
| Ferroptosis as a Translational Axis in Small Cell Lung Cancer: A Systematic Review of Redox Pathways and Precision Oncology Prospects. | Oncol Res | 2026 | 41930142 | PubTator, text mining | PubMed |
| Systematic Optimization of Proteolysis-Targeting Chimeras for PIN1 Enables Selective Degradation and Antitumor Activity In Vivo. | Pharmaceutics | 2026 | 41900774 | PubTator, text mining | PubMed |
| Forkhead box protein M1 network induction and crosstalk drives the development of alcohol-associated liver disease. | Hepatology | 2026 | 41894254 | PubTator, text mining | PubMed |
| Prospects and advances of PROTAC in the treatment of hematologic malignancies. | Exp Hematol Oncol | 2026 | 41845415 | PubTator, text mining | PubMed |
| Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances. | Mol Biomed | 2026 | 41826571 | PubTator, text mining | PubMed |
| The roles of post-translational modifications in the pathogenesis of RNA viruses: allies or adversaries? | Front Microbiol | 2026 | 41767575 | PubTator, text mining | PubMed |
| Exploring the PLD1-tau interaction in Frontotemporal Dementia. | bioRxiv | 2026 | 41726972 | PubTator, text mining | PubMed |
| Retraction: The HBV core protein and core particle both bind to the PPiase Par14 and Par17 to enhance their stabilities and HBV replication. | Front Microbiol | 2026 | 41725806 | PubTator, text mining | PubMed |
| Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer. | J Exp Clin Cancer Res | 2026 | 41673759 | PubTator, text mining | PubMed |
| Rooting Ability of Eucalyptus dunnii Maiden Mini-Cuttings Is Conditioned by Stock Plant Nighttime Temperature. | Plants (Basel) | 2026 | 41600142 | PubTator, text mining | PubMed |
| Based on 3D-QSAR modeling and molecular dynamics of novel peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 inhibitors design and screening. | Medicine (Baltimore) | 2026 | 41578563 | PubTator, text mining | PubMed |
| The Ess1 prolyl isomerase represses TERRA transcription and promotes telomere replication in Saccharomyces cerevisiae. | Genetics | 2026 | 41557636 | PubTator, text mining | PubMed |
| Predicting NMR Relaxation Using a First-Principles Brownian Dynamics Approach. | J Chem Theory Comput | 2026 | 41481771 | PubTator, text mining | PubMed |
| Kv4.2 Channels at the Crossroads of Excitability, Plasticity, and Synaptic Signaling. | Neuroscientist | 2026 | 41459943 | PubTator, text mining | PubMed |
| HBV X protein regulates cancer stemness and tumor invasiveness through SENP1 in hepatocellular carcinoma. | JHEP Rep | 2026 | 41438340 | PubTator, text mining | PubMed |
| The peptidyl-prolyl cis-trans isomerase, Pin1, is a regulator of the protein kinase C θ (PKCθ) catalytic activity in activated T cells. | Protein Sci | 2026 | 41427722 | PubTator, text mining | PubMed |
| Identification and characterization of peptidyl-prolyl isomerase Pin1 as a new regulatory component of BCR::ABL1 degradation. | Leuk Res | 2026 | 41371165 | PubTator, text mining | PubMed |
| Palladium(0) and Juglone: a new alliance in the fight against ovarian cancer. | Dalton Trans | 2026 | 41358905 | PubTator, text mining | PubMed |
| Editorial Expression of Concern: Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. | Cell Death Differ | 2026 | 41331103 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5300/papers?page=2